Listed

Celldex Therapeutics, Inc.: Form 10-Q for the period ended Jun 30, 2014

Filed with the SEC on Aug 7, 2014 and accepted by EDGAR at Aug 7, 2014, 09:01 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-04-01 to 2014-06-30$592.0kus-gaap:Revenues
Revenue6 months2014-01-01 to 2014-06-30$1.0mus-gaap:Revenues
Research and development3 months2014-04-01 to 2014-06-30$24.1mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2014-01-01 to 2014-06-30$51.2mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2014-04-01 to 2014-06-30−$28.5mus-gaap:OperatingIncomeLoss
Operating income6 months2014-01-01 to 2014-06-30−$60.0mus-gaap:OperatingIncomeLoss
Net income3 months2014-04-01 to 2014-06-30−$28.3mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Net income6 months2014-01-01 to 2014-06-30−$58.2mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Diluted EPS3 months2014-04-01 to 2014-06-30−$0.32us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2014-01-01 to 2014-06-30−$0.65us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2014-01-01 to 2014-06-30−$52.7mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure6 months2014-01-01 to 2014-06-30$1.1mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2014-06-30$40.8mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-06-30$255.6mus-gaap:AssetsCurrent
Total assetsAt period end2014-06-30$297.6mus-gaap:Assets
Current liabilitiesAt period end2014-06-30$21.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-06-30$32.3mus-gaap:Liabilities
Shareholders' equityAt period end2014-06-30$265.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001104659-14-057922. Last ingested by Listed: Nov 5, 2026, 19:04 ET. Listed shows no prices and gives no investment advice.